Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine (Q34514797)

2 August 2017

1 reference

title

Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine (English)

1 reference

2 August 2017

0 references

personalized medicine

1 reference

7

Tesshi Yamada

1 reference

2 August 2017

1

Kazufumi Honda

1 reference

2 August 2017

Masaya Ono

2

1 reference

2 August 2017

Miki Shitashige

3

1 reference

2 August 2017

Mari Masuda

4

1 reference

2 August 2017

Masahiro Kamita

5

1 reference

2 August 2017

Nami Miura

6

1 reference

2 August 2017

publication date

16 December 2012

1 reference

Japanese Journal of Clinical Oncology

2 August 2017

published in

1 reference

2 August 2017

volume

43

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

103-109

1 reference

Biomarkers in cancer staging, prognosis and treatment selection

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

The human proteome project: Current state and future direction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Proteomic technologies in modern biomedical science

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Clinical proteomics: translating benchside promise into bedside reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Proteomic applications for the early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Cancer proteomics by quantitative shotgun proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Large-scale quantitative clinical proteomics by label-free liquid chromatography and mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Antibody-based proteomics for human tissue profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

A human protein atlas for normal and cancer tissues based on antibody proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Towards a knowledge-based Human Protein Atlas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Antibody-based proteomics: fast-tracking molecular diagnostics in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Protein microarrays: molecular profiling technologies for clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Protein microarrays and novel detection platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Signal pathway profiling of prostate cancer using reverse phase protein arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Survival prediction for pancreatic cancer patients receiving gemcitabine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Ongoing and future developments at the Universal Protein Resource

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

PRIDE: the proteomics identifications database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Mass spectrometric protein identification using the global proteome machine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Open source system for analyzing, validating, and storing protein identification data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Possible detection of pancreatic cancer by plasma protein profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Altered plasma apolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Identification of a predictive biomarker for hematologic toxicities of gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Global, in vivo, and site-specific phosphorylation dynamics in signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

State-based discovery: a multidimensional screen for small-molecule modulators of EGF signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

The Human Protein Atlas as a proteomic resource for biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYS200

21 January 2018

Identifiers

DOI

10.1093/JJCO/HYS200

1 reference

2 August 2017

1 reference